Treatment for Brunner’s gland hyperplasia depends almost entirely on whether the growth is causing symptoms. Most cases are discovered incidentally during an endoscopy or imaging study done for another reason, and these typically require no treatment at all. When a lesion does cause problems, usually bleeding or obstruction, endoscopic removal is the first-line approach for most patients, with surgery reserved for large, complex, or suspicious-looking growths. Medical therapy with acid-suppressing drugs addresses one of the condition’s suspected triggers but rarely shrinks the lesion itself.
Why Most Cases Need No Treatment
Brunner’s glands are small mucus-secreting structures concentrated in the first part of the duodenum, just past the stomach. When they overgrow, the result is a benign, polypoid mass or a cluster of nodules. The condition is rare, and it is most often spotted by accident during endoscopic or radiologic evaluations performed for unrelated complaints.1ScienceDirect / Journal of Pediatric Surgery Case Reports. Brunner’s gland hyperplasia causing gastric outlet obstruction in a child: a case report A small, asymptomatic nodule that is confirmed benign on biopsy can simply be monitored. No medication or procedure is needed, and many people live with these growths without ever knowing they have them.
The decision to intervene hinges on two questions: Is the lesion causing symptoms? And does it look worrisome enough on imaging or biopsy to warrant removal for diagnostic certainty? If both answers are no, periodic surveillance with upper endoscopy is a reasonable strategy. This watch-and-wait approach works because the vast majority of Brunner’s gland lesions are benign proliferations with no tendency to grow quickly or transform into cancer.2PubMed Central. KRAS G12D mutation in Brunner gland adenoma
Symptoms That Change the Calculus
When Brunner’s gland hyperplasia does cause trouble, the two most common presentations are gastrointestinal bleeding and intestinal obstruction.3American Journal of Gastroenterology. Brunner’s Gland Hyperplasia: A Massive Duodenal Lesion Bleeding can range from slow, chronic blood loss that shows up as iron-deficiency anemia to acute episodes of vomiting blood or passing dark, tarry stools. In symptomatic patients, bleeding is the single most frequent complaint, and if the polyp grows large enough, it can partially or fully block the duodenal lumen, causing upper abdominal pain, vomiting, and a feeling of fullness after eating very little.4PubMed Central. Brunner’s gland hyperplasia: A rare cause of gastrointestinal bleeding – Section: Discussion
Less commonly, a large lesion near the ampulla of Vater can obstruct the bile or pancreatic duct, triggering pancreatitis or jaundice. Intussusception, where the duodenal wall telescopes into itself around the polyp, is another rare but serious complication.5Journal of Surgical Case Reports. Brunner’s gland hyperplasia: an unusual cause of hemorrhagic shock – Section: DISCUSSION Any of these scenarios moves the treatment plan from observation to active intervention.
Medical Therapy and Its Limits
Because chronic exposure to stomach acid is thought to be one driver of Brunner’s gland overgrowth, proton pump inhibitors and other acid-suppressing medications are sometimes prescribed. The logic makes sense on paper: reduce the acid load reaching the duodenum, and the glands may stop proliferating. In practice, medical treatment mainly addresses gastric hyperacidity, but actual regression of an established Brunner’s gland lesion is rare.6PubMed Central. Adenomatous Hyperplasia of Duodenal Brunner’s Glands: An Extremely Uncommon Imitation of Malignant Pathology – Section: Abstract
Acid suppression can help manage associated symptoms like dyspepsia or upper abdominal discomfort, and it may slow further growth, but it should not be treated as a definitive cure. If a patient has a symptomatic lesion, relying on medication alone is unlikely to resolve it. Most gastroenterologists view acid suppression as a supportive measure that may be used alongside endoscopic or surgical removal, not a standalone treatment.
Endoscopic Removal
For symptomatic or diagnostically uncertain lesions, endoscopic resection has become the preferred treatment. It avoids open surgery, allows the pathologist to examine the entire specimen, and typically involves a short recovery. Two main techniques are used, and the choice between them depends on the lesion’s size, shape, and depth of involvement.
Endoscopic Mucosal Resection
Endoscopic mucosal resection, or EMR, is the most commonly used technique for Brunner’s gland polyps. It involves injecting fluid beneath the lesion to lift it away from the deeper muscle layer, then snaring and removing it with an electrocautery loop. EMR works well for pedunculated (stalked) lesions and for broad-based ones that do not extend deeply into the duodenal wall. Even for larger lesions, EMR can be a viable option as long as the polyp is accessible, is not too broadly attached, and does not show significant involvement of the underlying muscle layer on pre-procedure imaging.7PubMed Central. Giant Brunner’s gland hyperplasia of the duodenum successfully resected en bloc by endoscopic mucosal resection: A case report – Section: DISCUSSION
The advantages of EMR are its relative simplicity and shorter procedure time compared with more advanced techniques. It carries a lower risk of perforation than deeper dissection methods. The main limitation is that very large or sessile lesions may need to be removed in pieces (piecemeal resection), which makes it harder for the pathologist to confirm that the entire lesion was excised.
Endoscopic Submucosal Dissection
Endoscopic submucosal dissection (ESD) is a more technically demanding alternative that allows the endoscopist to peel out even large lesions in a single piece. This en-bloc removal is especially valuable when the growth is large, when the base is broad and flat, or when there is any concern about dysplasia, because intact margins make pathologic assessment more reliable. Newer techniques, such as transpyloric traction wire-assisted ESD, have expanded what can be done safely in the duodenum. In one reported case, this approach provided excellent exposure of the base of a large pedunculated mass, allowed clear visualization during dissection, and resulted in complete symptom resolution with no recurrence at one-year follow-up.8VideoGIE. Transpyloric, traction wire-assisted endoscopic submucosal dissection for large Brunner gland hyperplasia
ESD does carry a higher risk of complications than EMR because the dissection plane is deeper and the duodenal wall is thinner than the stomach or colon. Delayed perforation and bleeding after duodenal ESD are recognized hazards, and emergency surgery is sometimes needed to manage them.9PubMed Central. Management of a large mucosal defect after duodenal endoscopic resection To reduce these risks, endoscopists have developed strategies for closing the wound left behind, including over-the-scope clips and special absorbable sheets sealed with fibrin glue to cover the raw tissue.9PubMed Central. Management of a large mucosal defect after duodenal endoscopic resection These advances have made duodenal ESD safer, though it still requires a highly skilled endoscopist and is typically performed at specialized centers.
The Role of Endoscopic Ultrasound Before Treatment
Before deciding on the best removal strategy, many gastroenterologists perform endoscopic ultrasound (EUS) to get a clearer picture of the lesion. Standard endoscopy shows what the surface looks like, but EUS reveals how deep the growth extends and whether it involves the muscle layer beneath the mucosa. Brunner’s gland lesions typically appear on EUS as masses arising from the submucosal layer, sometimes containing small cyst-like spaces that correspond to dilated glands.10PubMed Central. Endoscopic Ultrasonography Findings for Brunner’s Gland Hamartoma in the Duodenum
This information directly shapes the treatment decision. If EUS shows the lesion is confined to the submucosa with no muscle-layer involvement, endoscopic removal is usually safe. If EUS suggests deeper invasion or an irregular structure that raises concern about malignancy, the case may be referred for surgical excision instead. EUS also helps distinguish Brunner’s gland hyperplasia from other submucosal duodenal tumors, such as gastrointestinal stromal tumors or carcinoid tumors, which require entirely different management.
When Surgery Is Necessary
Surgery is reserved for a minority of cases. The most common scenarios that push treatment beyond the scope of endoscopy include lesions too large or too broadly attached for safe endoscopic removal, growths in technically difficult locations near the ampulla, lesions with biopsy results suggesting dysplasia or malignancy, and situations where the preoperative imaging mimics a pancreatic or duodenal cancer closely enough that the surgical team cannot safely rule it out without removing the mass.
The extent of surgery varies. A small, well-localized lesion may be removed by a limited duodenal resection or local excision. At the other extreme, diffuse nodular hyperplasia that encases the second portion of the duodenum and looks suspicious for pancreatic invasion on CT scanning can lead to a major operation. In one reported case, a patient with obstructive symptoms and imaging findings suspicious for cancer underwent a pancreaticoduodenectomy (the Whipple procedure), and the final pathology revealed Brunner’s gland hyperplasia rather than cancer.11PubMed Central. Brunner’s gland hyperplasia: treatment of severe diffuse nodular hyperplasia mimicking a malignancy on pancreatic-duodenal area – Section: Abstract That outcome underscores a frustrating reality: Brunner’s gland hyperplasia can look so much like a malignant tumor on imaging that the most aggressive operation is sometimes performed for what turns out to be a benign condition.6PubMed Central. Adenomatous Hyperplasia of Duodenal Brunner’s Glands: An Extremely Uncommon Imitation of Malignant Pathology – Section: Abstract
This is one of the strongest arguments for pursuing a thorough workup with EUS and biopsy before committing to surgery. A well-characterized benign lesion can often be managed endoscopically, sparing the patient a major abdominal operation.
How Real Is the Cancer Risk?
The question lingers for every patient told they have Brunner’s gland hyperplasia: could it turn into cancer? The short answer is that malignant transformation is possible but genuinely uncommon. Brunner’s gland hamartoma is considered a benign tumor, though it does carry a very low risk of progression into adenocarcinoma.12PubMed Central. Brunner’s Gland Hamartoma of the Duodenum: A Literature Review
The most detailed look at this question comes from a review of 722 cases of Brunner’s gland hyperplasia. Among those, about 2% showed dysplastic changes, which are the cellular abnormalities that can precede cancer.13ACG Case Reports Journal. Recurrence of Brunner Gland Adenocarcinoma After Duodenectomy and Gastrojejunostomy – Section: DISCUSSION A closer examination of these dysplastic cases found a spectrum ranging from low-grade to high-grade dysplasia, with a small number showing invasive carcinoma. The finding that these changes frequently coexisted in the same tumor suggests a stepwise progression, though one that only a small fraction of lesions ever follow.14PubMed. Gastric foveolar metaplasia with dysplastic changes in Brunner gland hyperplasia: possible precursor lesions for Brunner gland adenocarcinoma
For the individual patient, a 2% rate of dysplasia across all reported cases translates into a very small personal risk, especially if the lesion has been biopsied and shows no atypical cells. Still, the existence of a pathway from hyperplasia to carcinoma is the main reason gastroenterologists recommend complete removal of larger or symptomatic lesions rather than simply watching them indefinitely. Complete excision also provides the pathologist with the full architecture of the growth, which is the only way to conclusively rule out focal dysplasia that a small biopsy might miss.
Naming Confusion Around Brunner’s Gland Lesions
One thing that can frustrate patients researching this condition is the inconsistent terminology. You may see your pathology report refer to the growth as hyperplasia, hamartoma, adenoma, or simply a Brunner’s gland nodule. These terms have been used more or less interchangeably over the years, and the lines between them have never been firmly drawn.15PubMed Central. KRAS G12D mutation in Brunner gland adenoma – Section: Abstract In general, “hyperplasia” tends to describe a simpler overgrowth of the glands, while “hamartoma” implies a more heterogeneous mix of glands, ducts, smooth muscle, and fatty tissue. “Adenoma” suggests a more tumor-like architecture. In practice, many of these lesions share overlapping features, and the treatment approach does not change dramatically based on which label is used. What matters more than the name is whether the biopsy shows normal glandular tissue, dysplasia, or something more concerning.
If your report uses different terminology than what you have read online, ask your gastroenterologist to clarify the biopsy findings in plain terms. The specific histologic subtype matters less to your daily life than whether the cells look normal and whether the growth is causing symptoms.
Brunner’s Gland Hyperplasia and Kidney Disease
An interesting clinical association worth knowing about is the link between chronic kidney failure and Brunner’s gland overgrowth. In one study comparing patients with chronic renal failure to a control group, multiple duodenal polyps caused by circumscribed nodular hyperplasia of Brunner’s glands were found in a substantially higher proportion of the kidney-disease patients than in people without kidney problems.16PubMed Central. Multiple duodenal polyps in uraemia: a little known clinical entity The mechanism is not fully understood, but chronic kidney failure alters the chemical environment of the gut in several ways, including changes in gastric acid secretion and the accumulation of uremic toxins, either of which could stimulate the glands.
For patients on dialysis or being evaluated for a kidney transplant, this connection is worth flagging to the gastroenterologist if duodenal polyps turn up on an upper endoscopy. These polyps are still benign and are managed the same way as in the general population, but knowing the association can prevent unnecessary alarm and steer the workup toward the right diagnosis more efficiently.
What Recovery Looks Like After Endoscopic Removal
If you undergo EMR or ESD for a Brunner’s gland lesion, the recovery is generally straightforward. Most patients go home the same day or after a brief overnight observation, especially if the procedure was uncomplicated and the defect was closed during the endoscopy. You can expect to be on a liquid or soft diet for a few days, with gradual return to normal eating. Acid-suppressing medication is typically prescribed for several weeks afterward to help the resection site heal.
The main risks in the days following the procedure are delayed bleeding and perforation. Warning signs include severe abdominal pain, fever, vomiting blood, or passing large amounts of dark stool. These complications are uncommon but require prompt medical attention. Follow-up endoscopy is usually scheduled several months after removal to confirm healing and check for recurrence. Recurrence after complete endoscopic removal is rare for Brunner’s gland hyperplasia, which is another point in favor of this approach over long-term watchful waiting for symptomatic lesions.
For patients who undergo surgical excision, the recovery is naturally longer, proportional to the extent of the operation. A limited local excision heals within a couple of weeks, while a Whipple procedure involves a hospital stay of one to two weeks and a recovery period of several months. The vast majority of patients treated for Brunner’s gland hyperplasia, regardless of the method used, do well long-term, with resolution of symptoms and minimal risk of the condition coming back.